Stock MAPI PHARMA LTD
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Mapi Pharma Ltd Share Price

Equities

IL0011319600

Biotechnology & Medical Research

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Mapi Pharma Ltd
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Press releases Mapi Pharma Ltd

Mapi Pharma : Closes $10 Million Investment Led by Shavit Capital PU
Mapi Pharma : First Patient Treated in Mapi Pharma’s Phase IIa Clinical Trial of GA Depot for Relapsing Remitting Multiple Sclerosis (RRMS) PU
More press releases

Managers and Directors - Mapi Pharma Ltd

Managers TitleAgeSince
Ehud Marom CEO
 Chief Executive Officer 73 31/12/07
Nir Bernstein DFI
 Director of Finance/CFO 57 31/10/13
Laura Popper CTO
 Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Dov Pekelman BRD
 Director/Board Member 84 -
Ehud Marom CEO
 Chief Executive Officer 73 31/12/07
Itamar Borowitz BRD
 Director/Board Member 80 30/04/09
More insiders

Company Profile

More about the company

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+17.73% 124B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+16.88% 111B
BIONTECH SE Stock BioNTech SE
-9.04% 23.17B
ARGENX SE Stock argenx SE
+4.31% 22.94B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-38.15% 17.42B
BEIGENE, LTD. Stock BeiGene, Ltd.
-7.75% 17.42B
GENMAB A/S Stock Genmab A/S
-15.59% 16.9B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+3.42% 13.71B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+29.63% 11.82B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW